HKSE - Delayed Quote HKD

Concord Healthcare Group Co., Ltd. (2453.HK)

6.350
-0.030
(-0.47%)
At close: May 16 at 4:08:18 PM GMT+8
Loading Chart for 2453.HK
  • Previous Close 6.380
  • Open 6.320
  • Bid 6.350 x --
  • Ask 6.360 x --
  • Day's Range 6.160 - 6.650
  • 52 Week Range 5.770 - 55.000
  • Volume 5,369,800
  • Avg. Volume 1,699,231
  • Market Cap (intraday) 4.549B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.670
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company also offers oncology-related services, including sale and installation of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. The company was incorporated in 2008 and is based in Beijing, China.

www.concordmedical.com

567

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2453.HK

View More

Performance Overview: 2453.HK

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2453.HK
42.27%
HANG SENG INDEX (^HSI)
16.38%

1-Year Return

2453.HK
81.65%
HANG SENG INDEX (^HSI)
20.48%

3-Year Return

2453.HK
35.20%
HANG SENG INDEX (^HSI)
17.02%

5-Year Return

2453.HK
35.20%
HANG SENG INDEX (^HSI)
1.90%

Compare To: 2453.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2453.HK

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    4.55B

  • Enterprise Value

    7.66B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.81

  • Price/Book (mrq)

    2.55

  • Enterprise Value/Revenue

    18.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -114.14%

  • Return on Assets (ttm)

    -4.12%

  • Return on Equity (ttm)

    -25.72%

  • Revenue (ttm)

    388.3M

  • Net Income Avi to Common (ttm)

    -443.22M

  • Diluted EPS (ttm)

    -0.670

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    342.39M

  • Total Debt/Equity (mrq)

    169.58%

  • Levered Free Cash Flow (ttm)

    -480.98M

Research Analysis: 2453.HK

View More

People Also Watch